Repurposed drug against COVID-19: nanomedicine as an approach for finding new hope in old medicines. (19th May 2021)

• Record Type: Journal Article
• Authors: Ahmad, Mohammad Zaki; Ahmad, Javed; Aslam, Mohammed; Khan, Mohammad Ahmed; Alasmary, Mohammed Yahia; Abdel-Wahab, Basel A
• Is Part Of: Nano express. Volume 2:Number 2(2021)
• Publication Date: 2021-05-19
• Subjects: COVID-19 -- repurposed drug -- nanomedicine -- targeted therapy -- anti-viral -- pulmonary drug delivery; Nanotechnology -- Periodicals; Nanoscience -- Periodicals; 620.5
• DOI: 10.1088/2632-959X/abffed
• Languages: English
• ISSNs: 2632-959X

Abstract

Abstract: The coronavirus disease 2019 (COVID-19) has become a threat to global public health. It is caused by the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) and has triggered over 17 lakh causalities worldwide. Regrettably, no drug or vaccine has been validated for the treatment of COVID-19 and standard treatment for COVID-19 is currently unavailable. Most of the therapeutics moieties which were originally intended for the other disease are now being evaluated for the potential to be effective against COVID-19 (re-purpose). Nanomedicine has emerged as one of the most promising technologies in the field of drug delivery with the potential to deal with various diseases efficiently. It has addressed the limitations of traditional repurposed antiviral drugs including solubility and toxicity. It has also imparted enhanced potency and selectivity to antivirals towards viral cells. This review emphasizes the scope of repositioning of traditional therapeutic approaches, in addition to the fruitfulness of nanomedicine against COVID-19.